During the past decade, FBI "Scientific Research Institute of Oncology n. a. N. N. Petrov" conducted 64 clinical trials. In the 10-year time frame, 64 clinical trials started and 27 clinical trials were completed, i.e. on average, 42.2% percent of trials that started reached the finish line to date. In the past 5 years, 26 clinical trials started and 14 clinical trials were completed. i.e. 53.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "FBI "Scientific Research Institute of Oncology n. a. N. N. Petrov"" #1 sponsor was "Hoffmann-La Roche" with 24 trials, followed by "Biocad" with 9 trials sponsored, "N.N. Petrov National Medical Research Center of Oncology" with 8 trials sponsored, "Boehringer Ingelheim" with 4 trials sponsored and "Janssen Research & Development, LLC" with 4 trials sponsored. Other sponsors include 43 different institutions and companies that sponsored additional 41 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "FBI "Scientific Research Institute of Oncology n. a. N. N. Petrov"" #1 collaborator was "Hoffmann-La Roche" with 2 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "ADIR, a Servier Group company" with 1 trials as a collaborator, "Alliance Foundation Trials (AFT)" with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "FBI "Scientific Research Institute of Oncology n. a. N. N. Petrov"" are "Breast Cancer" (13 trials), "Carcinoma, Non-Small-Cell Lung" (9 trials), "Non-small Cell Lung Cancer" (5 trials), "Melanoma" (4 trials) and "Metastatic Breast Cancer" (3 trials). Many other conditions were trialed in "FBI "Scientific Research Institute of Oncology n. a. N. N. Petrov"" in a lesser frequency.

Most popular intervention types in "FBI "Scientific Research Institute of Oncology n. a. N. N. Petrov"" are "Drug" (79 trials), "Biological" (16 trials), "Procedure" (5 trials), "Other" (3 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "Paclitaxel" (14 trials), "Carboplatin" (13 trials), "Atezolizumab" (11 trials) and "Cisplatin" (9 trials). Other intervention names were less common.

The vast majority of trials in "FBI "Scientific Research Institute of Oncology n. a. N. N. Petrov"" are 75 trials for "All" genders, 18 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "FBI "Scientific Research Institute of Oncology n. a. N. N. Petrov"". undefined are not yet recruiting, 21 are recruiting, 25 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 38 completed trials in FBI "Scientific Research Institute of Oncology n. a. N. N. Petrov", undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in FBI "Scientific Research Institute of Oncology n. a. N. N. Petrov", 10 "Phase 1" clinical trials were conducted, 25 "Phase 2" clinical trials and 61 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 6 trials that are defined as “Not Applicable".

FBI "Scientific Research Institute of Oncology n. a. N. N. Petrov" has several departments that took part in Clinical trials: "FSI "SRC of Oncology n. a. N.N.Petrov of Rosmedtekhnologiy"" - 6 trials